Stage IVA Oropharyngeal Squamous Cell Carcinoma Terminated Phase 2 Trials for Cisplatin (DB00515)

IndicationStatusPhase
DBCOND0039579 (Stage IVA Oropharyngeal Squamous Cell Carcinoma)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02196168Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck CancerTreatment